The Adult ADHD Self-Report Scale (ASRS) v1.1 Symptom Checklist<\/strong> is an internationally recognized, 18-item self-administered psychometric instrument designed to assess the frequency and manifestation of current Attention-Deficit\/Hyperactivity Disorder (ADHD)<\/a> symptoms in adults aged 18 years and older. Developed in conjunction with the World Health Organization (WHO)<\/a> and the Workgroup on Adult ADHD\u2014including leading investigators from Harvard Medical School and the New York University Grossman School of Medicine\u2014the instrument directly operationalizes the 18 diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)<\/a>, which remain foundational in current DSM-5 clinical frameworks. The ASRS v1.1 structurally bifurcates into two clinical dimensions: Inattention<\/strong> (9 items) and Hyperactivity-Impulsivity<\/strong> (9 items). Respondents quantify symptom frequency over the preceding six months using a five-point Likert-type frequency metric ranging from 0 (“Never”) to 4 (“Very often”).<\/p>\n Rather than relying solely on continuous summation scores, the instrument incorporates a categorical “shaded box” threshold methodology, which accounts for item-specific psychometric weighting and minimizes self-report response bias. The initial six questions comprise the ASRS v1.1 Screener (Part A)<\/em>, which empirically captures the greatest predictive power for clinical ADHD caseness; endorsement of four or more positive responses in Part A signals high diagnostic likelihood warranting a comprehensive neuropsychiatric assessment. Psychometric evaluations demonstrate strong internal consistency (Cronbach’s $\\alpha = .84-.91$<\/span>), high test-retest reliability ($r = .58-.77$<\/span>), excellent specificity ($98.3%$<\/span>), and high total classification accuracy ($97.9%$<\/span>), establishing the tool as a gold standard in both clinical triaging and epidemiological investigations.<\/p>\n Adult ADHD, Attention-Deficit\/Hyperactivity Disorder, Adult ADHD Self-Report Scale, ASRS v1.1, Psychometrics, Screening Instruments, Inattention, Hyperactivity-Impulsivity, DSM-IV-TR, DSM-5, Diagnostic Utility, World Health Organization<\/p>\n The Adult ADHD Self-Report Scale v1.1 was conceptualized and calibrated by the World Health Organization Composite International Diagnostic Interview (CIDI) Advisory Group on Adult ADHD in collaboration with academic psychometricians and clinical psychiatrists:<\/p>\n The primary clinical and research objective of the Adult ADHD Self-Report Scale (ASRS) v1.1<\/strong> is to provide a standardized, psychometrically rigorous, and cost-effective screening tool capable of identifying current ADHD symptomatology in adults. Historically, ADHD<\/a> was conceptualized predominantly as a pediatric condition that remitted during late adolescence. However, contemporary longitudinal research establishes that clinically significant executive dysregulation persists into adulthood in 50% to 65% of individuals, frequently resulting in severe personal, occupational, academic, and interpersonal impairment.<\/p>\n Standard DSM diagnostic criteria were formulated around pediatric behavioral indicators, such as “runs about or climbs excessively” or “difficulty playing quietly.” When applied to adult clinical encounters, these juvenile criteria yielded notable diagnostic false negatives. The ASRS v1.1 was intentionally constructed to operationalize these underlying neurobehavioral symptoms into ecologically valid expressions representative of adult occupational, collegiate, and social environments. For example, references to academic play and classroom misconduct were systematically translated into concepts such as occupational procrastination, organizational paralysis, conversational impulsivity, and difficulty managing complex work-related projects.<\/p>\n Beyond individual clinical practice, the instrument serves pivotal epidemiological purposes as part of the World Mental Health (WMH) Survey Initiative<\/a>. Its brief administrative burden (approximately 3 to 5 minutes) makes it suitable for large-scale population surveys, college health center intakes, routine workplace evaluations, and specialized clinical settings where ADHD frequently exhibits high comorbidity\u2014such as substance use disorder (SUD) rehabilitation clinics, affective disorder clinics, and adult correctional facilities.<\/p>\n Crucially, the scale is designed strictly as a screening<\/em> and symptom-tracking<\/em> instrument, not an autonomous diagnostic instrument. It captures symptom frequency over the past six months but does not independently evaluate developmental onset prior to age 12, objective multi-setting functional impairment, or differential psychiatric diagnoses (e.g., bipolar mania, severe anxiety, major depressive disorder, or thyroid dysfunction). Thus, a positive ASRS screen operates as an empirical catalyst indicating the necessity of a complete psychiatric, medical, and developmental clinical evaluation.<\/p>\n The psychological construct evaluated by the ASRS v1.1 is the phenotypic manifestation of Attention-Deficit\/Hyperactivity Disorder in adulthood<\/strong>, defined as a persistent, neurodevelopmental dimensional continuum characterized by clinically impairing levels of inattention, disorganization, hyperactivity, and executive impulsivity. Within the DSM structural framework, the construct consists of two core dimensions:<\/p>\n The Inattention dimension reflects profound disruptions in executive attention networks, sustained mental effort, working memory capacity, and goal-directed action sequencing. In adults, inattention rarely presents as simple daydreaming; rather, it manifests across distinct behavioral domains:<\/p>\n In mature adults, the hyperactive-impulsive dimension transforms from the gross motor hyperactivity observed in pediatric cohorts into refined, internal subjective restlessness and deficient inhibitory control:<\/p>\n The development and construct architecture of the ASRS v1.1 are anchored within advanced neurobiological and neuropsychological paradigms of adult executive dysfunction, notably the Unified Theory of Executive Function and Behavioral Inhibition<\/strong> formulated by Russell A. Barkley<\/a>. Barkley’s model posits that the fundamental neurobehavioral lesion in ADHD is not merely an isolated attentional deficit, but a primary breakdown in behavioral inhibition<\/em>.<\/p>\n Under this theoretical framework, behavioral inhibition is composed of three interconnected processes: (a) inhibition of the initial prepotent response to an event, (b) interruption of an ongoing response that is proving ineffective, and (c) interference control (resistance to distraction). Deficits in behavioral inhibition disrupt four downstream executive neuropsychological functions:<\/p>\n Neurobiologically, the scale is underpinned by findings from neuroimaging and neurochemical investigations. Adult ADHD is characterized by structural and functional anomalies within the frontostriatal circuitry<\/strong>, specifically linking the dorsolateral prefrontal cortex (responsible for executive planning and working memory), the anterior cingulate cortex (regulating selective attention and conflict resolution), and the basal ganglia (mediating motor control and habit execution). These neural circuits depend heavily on optimal concentrations of the monoamine neurotransmitters dopamine<\/em> and norepinephrine<\/em>. In adults with ADHD, inadequate catecholaminergic tone impairs signal-to-noise ratio processing in the prefrontal cortex, precipitating executive failure, mind-wandering, and an inability to suppress default mode network (DMN) activity during goal-directed tasks.<\/p>\n By translating these intricate neuropsychological and biological phenomena into observable, self-evaluative frequency statements, the ASRS v1.1 bridges theoretical cognitive neuroscience with pragmatic clinical measurement.<\/p>\n The psychometric validity of the ASRS v1.1 has been substantiated across diverse clinical trials, epidemiologic community registries, and cross-cultural cohorts.<\/p>\n In the seminal validation study conducted by Kessler et al. (2005) through the WHO World Mental Health Survey Initiative, the psychometric properties of the 18-item scale and its 6-item screener were evaluated against blinded, clinician-administered, semi-structured diagnostic interviews using the Composite International Diagnostic Interview (CIDI)<\/a> and the clinician-administered Adult ADHD Clinical Diagnostic Scale (ACDS) v1.2. In a community sample of 154 adults, the six-item screener (Part A) achieved an outstanding total classification accuracy of 97.9%<\/strong>, with a specificity of 98.3%<\/strong>, an empirical sensitivity of 56.3%<\/strong>, and a Cohen’s kappa coefficient of $kappa = .58$<\/span><\/strong>, denoting substantial diagnostic agreement exceeding chance.<\/p>\n In subsequent clinical evaluations involving individuals with confirmed adult ADHD diagnoses (Adler et al., 2006), the instrument demonstrated a high concurrent validity correlation of $r = .83$<\/span><\/strong> with clinician-rated ADHD rating scales. Receiver Operating Characteristic (ROC) curve analyses by Kessler et al. (2007) in a representative sample of 668 managed care organization enrollees demonstrated an Area Under the Curve (AUC) of 0.94<\/strong> for the 6-item screener and 0.92<\/strong> for the full 18-item scale, validating the screener’s discriminative ability.<\/p>\n The ASRS demonstrates strong convergent validity with alternative validated adult ADHD inventories, exhibiting robust correlations ($r = .65-.82$<\/span>) with the Conners’ Adult ADHD Rating Scales (CAARS)<\/em> and the Wender Utah Rating Scale (WURS)<\/em>. Discriminant validity has been demonstrated in clinical populations presenting with overlapping psychiatric conditions, including major depressive disorder, generalized anxiety disorder, and borderline personality disorder. Research by Dakwar et al. (2012) in substance use disorder (SUD) treatment populations confirmed that the ASRS Part A effectively parsed authentic neurodevelopmental ADHD from transient intoxication and withdrawal sequelae, retaining strong positive and negative predictive values when interpreted with standard cutoff thresholds.<\/p>\n Cross-cultural adaptations have yielded comparable psychometric profiles worldwide:<\/p>\n The reliability indices for the ASRS v1.1 indicate substantial measurement precision across clinical, non-clinical, and multi-cultural cohorts:<\/p>\n Across validation studies, the full 18-item ASRS v1.1 exhibits high internal consistency. In the clinical validation conducted by Adler et al. (2006), Cronbach’s alpha was documented at $\\alpha = .84$<\/span><\/strong> for the total scale score. Subscale analyses consistently yield strong reliability coefficients:<\/p>\n Temporal stability evaluations demonstrate that the ASRS v1.1 maintains consistency over discrete time intervals. Kessler et al. (2007) administered the instrument across a 2- to 4-week interval, reporting test-retest intraclass correlation coefficients (ICC) ranging between $r = .58$<\/span><\/strong> and $r = .77$<\/span><\/strong> across community samples. In clinical stability studies involving medicated versus unmedicated cohorts, test-retest reliability among stable unmedicated adult outpatients reached values as high as $r = .86$<\/span><\/strong>, confirming that the scale is resistant to minor transient situational fluctuations while remaining sensitive to genuine clinical treatment effects (such as initiation of central nervous system stimulant pharmacotherapy).<\/p>\n Structural evaluations of the ASRS v1.1 using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) demonstrate empirical support for the theoretical dual-construct foundation of ADHD.<\/p>\n Principal Component Analyses and exploratory factor extractions with promax or oblimin oblique rotations (recognizing the natural inter-correlation between ADHD dimensions) typically reveal a two-factor solution<\/strong> corresponding to the DSM-IV\/DSM-5 domains:<\/p>\n Structural equation modeling studies across international cohorts confirm acceptable fit for the correlated two-factor model, as well as a bi-factor model<\/strong> incorporating a generalized ADHD latent factor alongside two orthogonal group factors (Inattention and Hyperactivity\/Impulsivity). Typical goodness-of-fit indices reported in the literature include:<\/p>\n These structural data demonstrate that while Inattention and Hyperactivity-Impulsivity represent related components of a common neurodevelopmental syndrome (latent factor correlation $r \\approx .55-.70$<\/span>), they remain psychometrically distinct, validating their presentation as both independent subscale scores and a combined diagnostic screener.<\/p>\n The ASRS v1.1 is structured as a clear, self-administered questionnaire that can be completed via paper-and-pencil or integrated digital health platforms:<\/p>\n The Adult ADHD Self-Report Scale (ASRS) v1.1 was released in 2005<\/strong> by the World Health Organization (WHO) Workgroup on Adult ADHD. To support broad public health access, the scale was placed in the public domain and is available free of charge<\/strong> for non-commercial clinical, educational, and academic research applications.<\/p>\n Clinicians and researchers can access, print, and utilize the ASRS v1.1 without explicit written permission or licensing royalties, provided that the instrument’s original text, structure, attribution notices, and copyright disclaimers acknowledging the World Health Organization remain intact. For commercial deployment, inclusion within proprietary electronic medical record (EMR) software platforms, or integration into commercial clinical trials, consultation and permission from the WHO or the relevant copyright administrators may be required.<\/p>\n Adler, L. A., Spencer, T., Faraone, S. V., Kessler, R. C., Howes, M. J., Biederman, J., & Secnik, K. (2006). Validity of pilot Adult ADHD Self-Report Scale (ASRS) to rate adult ADHD symptoms. Annals of Clinical Psychiatry<\/em>, 18(3), 145\u2013148. https:\/\/doi.org\/10.1080\/10401230600801077<\/a><\/p>\n Adler, L. A., Shaw, D. M., Sitt, D. J., Maya, E., & Morrill, M. S. (2012). Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Primary Care Companion for CNS Disorders<\/em>, 14(3), PCC.11m01275. https:\/\/doi.org\/10.4088\/PCC.11m01275<\/a><\/p>\n Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin<\/em>, 121(1), 65\u201394. https:\/\/doi.org\/10.1037\/0033-2909.121.1.65<\/a><\/p>\n Dakwar, E., Mahony, M. A., Pavlicova, M., Glass, M. A., Brooks, M. D., Mariani, J. J., Bisaga, A., Fallu, A., & Levin, F. R. (2012). The utility of attention-deficit\/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. The Journal of Clinical Psychiatry<\/em>, 73(11), e1372\u2013e1378. https:\/\/doi.org\/10.4088\/JCP.12m07831<\/a><\/p>\n Herrmann, M. J., Saathoff, C., Schreppel, T. J., Ehlis, A. C., Scheuerpflug, P., Pauli, P., & Fallgatter, A. J. (2009). The effect of ADHD symptoms on performance monitoring in a non-clinical population. Psychiatry Research<\/em>, 169(2), 144\u2013148. https:\/\/doi.org\/10.1016\/j.psychres.2008.06.015<\/a><\/p>\n Hines, J. L., King, T. S., & Curry, W. J. (2012). The adult ADHD self-report scale for screening for adult attention deficit\u2013hyperactivity disorder (ADHD). The Journal of the American Board of Family Medicine<\/em>, 25(6), 847\u2013853. https:\/\/doi.org\/10.3122\/jabfm.2012.06.120065<\/a><\/p>\n Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J., Jin, R., Secnik, K., Spencer, T., \u00dcst\u00fcn, T. B., & Walters, E. E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychological Medicine<\/em>, 35(2), 245\u2013256. https:\/\/doi.org\/10.1017\/s0033291704002892<\/a><\/p>\n2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
5. Psychological Construct<\/h2>\n
Inattention (Items 1\u20134, 7\u201311)<\/h3>\n
\n
Hyperactivity-Impulsivity (Items 5\u20136, 12\u201318)<\/h3>\n
\n
6. Theoretical Framework<\/h2>\n
\n
7. Validity<\/h2>\n
Construct and Criterion Validity<\/h3>\n
Convergent and Discriminant Validity<\/h3>\n
Cross-Cultural Validity<\/h3>\n
\n
8. Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Reliability<\/h3>\n
9. Factor Analysis<\/h2>\n
Exploratory Factor Analysis (EFA)<\/h3>\n
\n
Confirmatory Factor Analysis (CFA) and Model Fit<\/h3>\n
\n
10. Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
\n
\n
11. Permissions & Fee and Test Year<\/h2>\n
12. References<\/h2>\n